CYTOKINETICS INC
CYTK
DELAYED 1 MONTH
35 insider filings · Latest: Jul 30, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jul 30, 2026 | Jul 30 8:26 PM | Andrew CallosEVP, Chief Commercial Officer | Sale | 14,000 | $79.88 | $1.1M | 58,555(D) | View → |
| Jul 27, 2026 | Jul 27 8:33 PM | Robert I BlumDirector, President & CEO | Sale | 7,500 | $80.87 | $606.5K | 377,820(D) | View → |
| Jun 9, 2026 | Jun 9 9:40 PM | Fady Ibraham MalikEVP Research & Development | Sale | 3,500 | $67.98 | $237.9K | 153,902(D) | View → |
| Jun 1, 2026 | Jun 1 10:54 PM | Edward M. Kaye MDDirector | Sale | 2,933 | $76.09 | $223.2K | 10,283(D) | View → |
| Jun 1, 2026 | Jun 1 10:51 PM | Andrew CallosEVP, Chief Commercial Officer | Sale | 15,000 | $74.08 | $1.1M | 58,555(D) | View → |
| Jun 1, 2026 | Jun 1 10:49 PM | Lynne B ParshallDirector | Sale | 5,000 | $74.08 | $370.4K | 15,784(D) | View → |
| May 27, 2026 | May 28 8:21 PM | Robert I BlumDirector, President & CEO | Sale | 7,500 | $77.21 | $579.1K | 392,830(D) | View → |
| May 19, 2026 | May 20 8:00 PM | Fady Ibraham MalikEVP Research & Development | Sale | 3,500 | $75.69 | $264.9K | 153,902(D) | View → |
| May 14, 2026 | May 14 8:26 PM | Robert I BlumDirector, President & CEO | Sale | 7,500 | $77.92 | $584.4K | 400,330(D) | View → |
| May 5, 2026 | May 5 9:35 PM | Fady Ibraham MalikEVP Research & Development | Sale | 3,500 | $77.37 | $270.8K | 153,902(D) | View → |
| May 5, 2026 | May 5 8:20 PM | Wendell WierengaDirector | Sale | 4,032 | $75.00 | $302.4K | 32,637(D) | View → |
| May 5, 2026 | May 5 8:18 PM | Sung LeeEVP, Chief Financial Officer | Sale | 23,906 | $76.87 | $1.8M | 63,221(D) | View → |
| May 5, 2026 | May 5 8:15 PM | John T HendersonDirector | Sale | 20,000 | $75.97 | $1.5M | 75,237(D) | View → |
| May 5, 2026 | May 5 8:11 PM | Andrew CallosEVP, Chief Commercial Officer | Sale | 11,333 | $77.25 | $875.5K | 58,555(D) | View → |
| May 1, 2026 | May 4 8:01 PM | Andrew CallosEVP, Chief Commercial Officer | Sale | 15,857 | $65.00 | $1.0M | 58,555(D) | View → |
| Apr 30, 2026 | Apr 30 8:22 PM | Andrew CallosEVP, Chief Commercial Officer | Sale | 15,000 | $63.26 | $948.9K | 58,555(D) | View → |
| Mar 16, 2026 | Mar 16 9:14 PM | Andrew CallosEVP, Chief Commercial Officer | Sale | 1,709 | $61.03 | $104.3K | 46,149(D) | View → |
| Mar 9, 2026 | Mar 10 10:05 PM | Andrew CallosEVP, Chief Commercial Officer | Sale | 2,582 | $60.72 | $156.8K | 47,858(D) | View → |
| Mar 9, 2026 | Mar 10 10:03 PM | Fady Ibraham MalikEVP Research & Development | Sale | 2,907 | $60.72 | $176.5K | 138,629(D) | View → |
| Mar 9, 2026 | Mar 10 10:00 PM | Robert I BlumDirector, President & CEO | Sale | 7,931 | $60.72 | $481.6K | 391,673(D) | View → |
Page 1 of 2
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 15, 2026 | Mar 17 8:11 PM | Robert I BlumDirector, President & CEO | Grant/Award | 113,529 | $60.06 | 111,864(D) | View → |
| Mar 15, 2026 | Mar 17 8:08 PM | Andrew CallosEVP, Chief Commercial Officer | Grant/Award | 31,145 | $60.06 | 29,480(D) | View → |
| Mar 15, 2026 | Mar 17 8:06 PM | Jeffrey HessekielChief Legal & Admin Officer | Grant/Award | 31,145 | $60.06 | 22,820(D) | View → |
| Mar 15, 2026 | Mar 17 8:05 PM | Sung LeeEVP, Chief Financial Officer | Grant/Award | 31,145 | $60.06 | 29,480(D) | View → |
| Mar 15, 2026 | Mar 17 8:03 PM | Fady Ibraham MalikEVP Research & Development | Grant/Award | 41,192 | $60.06 | 39,527(D) | View → |
| Mar 5, 2026 | Mar 5 9:27 PM | Andrew CallosEVP, Chief Commercial Officer | Option Exercise | 26,000 | $39.13 | 69,000(D) | View → |
← Previous
Page 2 of 2